Bioventus Inc.
BVS
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprā¦ read more
Healthcare
Medical Devices
5 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$13.47
Price+2.28%
$0.30
1Y
Price
Market Cap
$912.566m
Small
Price/Earnings 3y Avg5y Avg
18x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+15.2%
EBITDA Margin+2.4%
Net Profit Margin+6.3%
Free Cash Flow Margin+15.2%
EBITDA Margin+2.4%
Net Profit Margin+6.3%
Free Cash Flow MarginRevenue
$576.300m
+1.5%
1y CAGR+4.1%
3y CAGR+3.1%
5y CAGREarnings
$28.482m
+25.3%
1y CAGR+90.5%
3y CAGR+68.3%
5y CAGREPS
$0.41
+24.2%
1y CAGR+88.9%
3y CAGR+67.7%
5y CAGRBook Value
$234.265m
$650.539m
Assets$416.274m
Liabilities$272.076m
DebtDebt to Assets
41.8%
2.6x
Debt to EBITDAFree Cash Flow
$100.628m
+40.9%
1y CAGR+167.8%
3y CAGR+164.1%
5y CAGRNo items found.
Press Releases
Statements and updates from the company